Renaissance Technologies
AVNR

Renaissance Technologies’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Renaissance Technologies’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-884,514
Closed -$15M – 3537
2014
Q4 		$15M Buy
884,514
+826,500
+1,425% +$11.6M 0.04% 649
2014
Q3 		$692K Buy
+58,014
New +$396K ﹤0.01% 2201

Renaissance Technologies's AVNR Position: Q1 2015 in Review

Renaissance Technologies sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 884,514 shares — an estimated $15M sold.

Renaissance Technologies first reported a position in AVNR in Q3 2014 and held it in 2 quarters. The position peaked at $15M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Renaissance Technologies reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Renaissance Technologies sold 884,514 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $15M.
  • Renaissance Technologies first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 2 quarters.
  • Renaissance Technologies's AVANIR PHARMACEUTICALS, INC CL A position peaked at $15M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Renaissance Technologies's 13F filing for Q1 2015, filed 13 May 2015.